Gland Pharma Share Price Target Tomorrow 2024 To 2030 and More Details

Gland Pharma Ltd is an Indian pharmaceutical company known for its expertise in producing injectable medicines. Founded in 1978, the company manufactures a wide range of high-quality generic injectable products, which are used in hospitals and clinics for various medical treatments. Gland Pharma Share Price on NSE as of 5 November 2024 is 1,822.00 INR. Here will provide you more details on Gland Pharma Share Price Target 2024, 2025, 2026 to 2030.

Gland Pharma Ltd: Market Overview

• Open Price: ₹1,601.00
• High Price: ₹1,850.00
• Low Price: ₹1,600.00
• Previous Close: ₹1,610.90
• Volume: 5,756,461
• Value (Lacs): ₹105,507.30
• VWAP: ₹1,788.57
• UC Limit: ₹1,933.05
• LC Limit: ₹1,288.75
• P/E ratio: 41.57
• Div yield: 1.10%
• 52-wk high: ₹2,220.95
• 52-wk low: ₹1,509.30
• Mkt cap: ₹30.21KCr
• Face Value: ₹1

Gland Pharma Ltd Competitors

Here are four competitor companies of Gland Pharma Ltd, along with their approximate market capitalizations:

1. Sun Pharmaceutical Industries Ltd
   • Market Capitalization: Approximately ₹2,60,000 crores
2. Cipla Ltd
   • Market Capitalization: Approximately ₹1,10,000 crores
3. Dr. Reddy’s Laboratories Ltd
   • Market Capitalization: Approximately ₹95,000 crores

4. Aurobindo Pharma Ltd

   • Market Capitalization: Approximately ₹40,000 crores

Gland Pharma Share Price Chart

Gland Pharma Share Price Target Tomorrow 2024 To 2030

Gland Pharma Share Price Target 2024

Gland Pharma share price target 2024 Expected target could be ₹2230. Here are three key factors that could affect the growth of Gland Pharma’s Share Price Target in 2024:

• Regulatory Approvals and Compliance: Gland Pharma’s growth depends on timely regulatory approvals for its products in key markets like the United States and Europe. Efficiently navigating complex regulatory requirements and maintaining high-quality standards can help the company expand its product offerings, boosting revenue and positively impacting its share price.
• Expansion in Domestic and International Markets: Gland Pharma’s efforts to increase its footprint in both domestic and international markets will be crucial for growth. Expanding into new regions and forming strategic partnerships can drive sales, enhance brand recognition, and ultimately support share price growth.

• Product Innovation and R&D Investment: Continued investment in research and development, especially for specialized and complex injectables, can keep Gland Pharma competitive. New product launches, especially in high-demand therapeutic areas, can boost market share and revenues, positively influencing the company’s share price trajectory in 2024.

Gland Pharma Share Price Target 2025

Gland Pharma share price target 2025 Expected target could be ₹2545. Here are three risks and challenges that could affect the Gland Pharma Share Price Target in 2025:

• Regulatory Hurdles and Compliance Costs: As Gland Pharma operates in multiple international markets, it faces stringent regulatory requirements, especially in the U.S. and European markets. Any delays in approvals or compliance issues can lead to product recalls or fines, impacting revenue and investor confidence, potentially causing share price fluctuations.
• Intense Competition in Generic Injectables: The global market for generic injectables is highly competitive, with numerous pharmaceutical companies vying for market share. Increased competition can lead to price pressures, which may reduce Gland Pharma’s profit margins and limit its ability to raise prices, potentially impacting its financial performance and share price.

• Dependence on Key Markets: A significant portion of Gland Pharma’s revenue comes from major markets like the U.S. Any changes in market dynamics, such as shifts in demand, policy changes, or pricing regulations in these regions, could affect sales and profitability. Heavy reliance on key markets introduces revenue volatility risks, which could impact the share price if these markets underperform.

Gland Pharma Share Price Target 2030

Gland Pharma share price target 2030 Expected target could be ₹4025. Here are three risks and challenges that could affect the Gland Pharma Share Price Target in 2030:

• Rising Competition and Market Saturation: By 2030, the injectable and generic pharmaceuticals market may become increasingly saturated, with more companies entering the field and expanding their portfolios. This intensified competition could lead to price wars and reduced market share, putting pressure on Gland Pharma’s revenue growth and profit margins.
• Supply Chain Vulnerabilities: Pharmaceutical manufacturing relies heavily on the timely and cost-effective supply of raw materials and active pharmaceutical ingredients (APIs). Disruptions in the supply chain—due to geopolitical tensions, trade restrictions, or natural disasters—could affect production, increase costs, and impact Gland Pharma’s ability to meet demand, potentially influencing its share price negatively.

• Technological and R&D Challenges: The pharmaceutical industry is rapidly evolving, with advancements in biotechnology, drug delivery systems, and personalized medicine. Gland Pharma will need to invest heavily in research and development to keep pace with these innovations. Failure to adapt to new technologies or launch competitive products could lead to a loss of market relevance and investor interest, impacting the share price by 2030.

Gland Pharma Ltd Shareholding Pattern

• Promoters: 51.83%
• Mutual Funds: 32.83%
• Retail and Others: 8.32%
• FII: 4.47%
• DII: 2.54%

FOR MORE DETAIL FOLLOW THE OFFICIAL WEBSITE: https://glandpharma.com/

Gland Pharma Ltd Financials

Read Also:- E2E Networks Share Price Target Tomorrow 2024 To 2030 and More Details